IP Library › Granted Patent US 5,843,705
Granted Patent Utility
US 5,843,705 · App. 08/391,743

Transgenically produced antithrombin III

Inventors: Paul DiTullio, Harry Meade, Edward S. Cole
Patented Case View Patent ↗
Granted: Dec 1, 1998 Filed: Feb 21, 1995
Inventors
Paul DiTullio
Harry Meade
Edward S. Cole
Assignee (at issue)
Genzyme Transegenic Corporation

This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.

Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 5,843,705
App. No.
08/391,743
Filed
1995-02-21
Granted
1998-12-01
Kind
A